Ehlers–Danlos Syndrome: Understanding a Complex Connective Tissue Disorder. By: Ayomide Makinde



Introduction.

Ehlers-Danlos syndromes (EDS) are a group of 13 inherited connective

tissue disorders caused by genetic changes that affect the body's

connective tissues, which provide support and strength to the skin,

joints, blood vessels, and internal organs. Each type of EDS has its own

distinct set of characteristics and diagnostic criteria. However, many

people with EDS experience common features such as joint

hypermobility (unusually flexible joints), skin hyperextensibility (skin

that stretches more than usual), and tissue fragility. EDS is estimated to

affect approximately one in every 5,000 people worldwide and can occur

in individuals of any sex, race, or ethnic background.


Main Body

EDS is caused by genetic changes that affect connective tissue - It is

especially caused by a faulty gene that causes your body to produce not

enough collagen. Since the function of collagen is to maintain support

across the connective tissues in your body, having the condition can

result in overly flexible joints and fragile skin. There are 13 recognised

types of Ehlers-Danlos syndromes (EDS) and they are as follows -

● Arthrochalasia EDS (aEDS)

● Brittle cornea syndrome (BCS)

● Cardiac valvular EDS (cvEDS)

● Classical EDS (cEDS)


● Classical-like EDS (clEDS)

● Dermatosparaxis (dEDS)

● Hypermobile EDS (hEDS)

● Kyphoscoliotic EDS (kEDS)

● Musculocontractural EDS (mcEDS)

● Myopathic EDS (mEDS)

● Periodontal EDS (pEDS)

● Spondylodysplastic EDS (spEDS)

● Vascular EDS (vEDS)


Symptoms



Diagnosis

For many individuals with Ehlers-Danlos syndrome (EDS), obtaining a

diagnosis is often a lengthy and challenging process. Limited awareness

of the condition among healthcare professionals means that the signs

and symptoms are frequently overlooked or misinterpreted. As a result,

many people are initially diagnosed with other conditions, such as


fibromyalgia, myalgic encephalomyelitis/chronic fatigue syndrome

(ME/CFS), or irritable bowel syndrome (IBS), depending on the

symptoms they present. It is not uncommon for individuals to wait

many years, or even decades, before receiving an accurate diagnosis,

and some may never be diagnosed at all. However, receiving a correct

diagnosis is essential, as it enables appropriate management, access to

specialist care, and a better understanding of the condition.

Common Treatments for EDS

● Physiotherapy - The main treatment for most people with EDS.

Physiotherapy helps strengthen muscles, improve joint stability,

reduce pain, and lower the risk of joint dislocations.

● Pain management -Pain can be managed with medications such

as paracetamol, non-steroidal anti-inflammatory drugs (NSAIDs),

or, in some cases, stronger prescription medications under

medical supervision. Referral to a specialist pain clinic may also be

beneficial.

● Occupational therapy - Occupational therapists provide advice on

joint protection, energy conservation (pacing), adaptive

equipment, and strategies to make daily activities easier.

● Exercise -Low impact activities such as swimming, cycling, and

Pilates can improve muscle strength and cardiovascular fitness

while minimising stress on the joints. High-impact sports and

contact sports are generally discouraged.

● Surgery - Surgery is usually considered only when absolutely

necessary because fragile connective tissue can make healing

more difficult and increase the risk of complications.

● Lifestyle modifications - Pacing activities, maintaining a healthy

weight, avoiding excessive strain on joints, and learning

self-management techniques can help reduce symptoms and

improve day to day functioning


Why Awareness Matters

Awareness of Ehlers-Danlos syndromes is essential because it can lead

to earlier diagnosis, reduce the risk of misdiagnosis, and ensure that

individuals receive appropriate treatment and specialist care. Greater

understanding among healthcare professionals and the public can

improve patients' quality of life, help prevent complications, and provide

access to the support they need. In addition, raising awareness

promotes research into EDS, increasing the likelihood of improved

treatments and better outcomes for those living with these lifelong

connective tissue disorders.


Conclusion.

As research continues to advance our understanding of the genetic and

biological mechanisms underlying EDS, there is hope that new

therapies and improved standards of care will become available. Until

then, education, awareness, and continued support remain vital in

ensuring that people with Ehlers-Danlos syndromes receive the

recognition, care, and understanding they deserve.

References.

The Ehlers-Danlos Society. (2017). What is EDS? The Ehlers Danlos

Society. https://www.ehlers-danlos.com/what-is-eds/

Ehlers-Danlos Syndrome (EDS). (2025). Childrenshospital.Org.

https://www.childrenshospital.org/conditions-treatments/ehlers-danlos

-syndrome

Harrod, A. (2022, May 5). The Importance of Raising Awareness for EDS and

HSD within Society. Bursting With Potential.


https://burstingwithpotential.co.uk/the-importance-of-raising-awarene

ss-for-eds-and-hsd-within-society/

Livi. (2022, September 16). Livi.

https://www.livi.co.uk/medical-advice/musculoskeletal/ehlers-danlos-sy

ndrome/

The Ehlers-Danlos Support UK. (2021). The Ehlers-Danlos Support UK.

https://www.ehlers-danlos.org/what-is-eds/information-on-eds/diagno

sis

Ehlers Danlos Syndrome (EDS). (2026). East Genomics.

https://www.eastgenomics.nhs.uk/for-healthcare-professionals/clinical

-genetics-services/east-anglian-medical-genetics-service/referrals/refe

rrals-not-routinely-accepted/ehlers-danlos-syndrome-eds/

Orthopedic Management of the Ehlers-Danlos Syndromes (for Non-experts)

- The Ehlers Danlos Society. (2022, March 14). The Ehlers Danlos Society.

https://www.ehlers-danlos.com/2017-eds-classification-non-experts/or

thopedic-management-ehlers-danlos-syndrome

Ehlers-Danlos Syndrome. (2024). Medlineplus; National Library of

Medicine.

https://medlineplus.gov/ehlersdanlossyndrome.html?utm_source=es/

Comments

Popular posts from this blog

Understanding Ehlers-Danlos Syndrome (EDS) By: Zella Shanks (Current Campaign)

Uncovering the Clinical Characterization and Mechanisms of Fibrodysplasia Ossificans Progressiva (FOP) By: Sharen Rego

Understanding Cystic Fibrosis